Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Toronto Stock Exchange  >  Cipher Pharmaceuticals Inc    CPH   CA17253X1050

CIPHER PHARMACEUTICALS INC (CPH)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Toronto Stock Exchange
07/16/2018 07/17/2018 07/18/2018 07/19/2018 07/20/2018 Date
2.77(c) 2.75(c) 2.8(c) 2.83(c) 2.76(c) Last
9 475 5 150 6 818 1 100 15 937 Volume
-3.15% -0.72% +1.82% +1.07% -2.47% Change
More quotes
Financials (USD)
Sales 2018 27,2 M
EBIT 2018 10,4 M
Net income 2018 16,3 M
Finance 2018 19,1 M
Yield 2018 -
Sales 2019 33,7 M
EBIT 2019 13,8 M
Net income 2019 -
Finance 2019 36,9 M
Yield 2019 -
P/E ratio 2018 4,04
P/E ratio 2019 3,68
EV / Sales2018 1,36x
EV / Sales2019 0,57x
Capitalization 56,1 M
More Financials
Company
Cipher Pharmaceuticals, Inc. is a specialty pharmaceutical company, which engages in the robust and diversified portfolio of commercial and late-stage products.It also acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and... 
Sector
Pharmaceuticals
Calendar
10/31Earnings Release
More about the company
Latest news on CIPHER PHARMACEUTICALS INC
06/06CIPHER PHARMACEUTICALS : Adds New Vice President, Scientific & Medical Affairs
AQ
05/17SYNERGY PHARMACEUTICALS : Reports First Quarter 2018 Financial Results and Busin..
AQ
05/17CIPHER PHARMACEUTICALS : Reports Q1 2018 Results
AQ
05/15CIPHER PHARMACEUTICALS : Completes Acquisition of Canadian Business Portfolio of..
AQ
05/11CIPHER PHARMACEUTICALS : Reports Voting Results for the Election of Directors
AQ
05/10CIPHER PHARMACEUTICALS : Reports Q1 2018 Results
AQ
05/07CIPHER PHARMACEUTICALS : Notice of Cipher Pharmaceuticals Q1 2018 Conference Cal..
AQ
05/01CIPHER PHARMACEUTICALS : Notice of Cipher Pharmaceuticals Q1 2018 Conference Cal..
AQ
04/30CIPHER PHARMACEUTICALS : Proposes Adding Dr. Laurence Terrisse-Rulleau to Board ..
AQ
04/27CIPHER PHARMACEUTICALS : to Present at 2018 Bloom Burton & Co. Healthcare Invest..
AQ
More news
Sector news : Pharmaceuticals - NEC
03:02pBRISTOL MYERS SQUIBB : Myers Chief Commercial Officer Gordon Resigns
DJ
10:43aCHINA'S LATEST CONSUMER SCANDAL : Unsafe Vaccines
DJ
08:16aSHIRE PLC SHIRE PLC : Notice Of Results
DJ
07/20GLAXOSMITHKLINE : considers splitting up the group - FT
RE
07/20PFIZER : Biosimilar of Amgen's Neupogen Approved for Sale in the U.S.
DJ
More sector news : Pharmaceuticals - NEC
Latest Tweets
07/01Insider Buying: Cipher Pharmaceuticals Inc $CPH Insider Buys 10,000 Shares of.. 
05/30GeneNews Ltd : Today’s Research Reports on GeneNews, Cipher Pharmaceuticals, .. 
05/19Christian Godin Buys 5,000 Shares of Cipher Pharmaceuticals $CPH Stock  
05/19Cipher Pharmaceuticals $CPH Director Purchases C$17,950.00 in Stock  
05/15Correvio Pharma Corp Completes Strategic Transaction with Cipher Pharmaceutic.. 
More tweets
Qtime:8
News from SeekingAlpha
05/31SYNERGY PHARMA : Is Management Really That Bad? 
05/11Cipher's (CPHRF) CEO Robert Tessarolo on Q1 2018 Results - Earnings Call Tran.. 
05/10Cipher Pharmaceuticals reports Q1 results 
04/23Is Cipher Pharmaceuticals' Turnaround Going Unnoticed? 
2017Cipher's (CPHR) CEO Robert Tessarolo on Q1 2017 Results - Earnings Call Trans.. 
Chart CIPHER PHARMACEUTICALS INC
Duration : Period :
Cipher Pharmaceuticals Inc Technical Analysis Chart | 4-Traders
Full-screen chart
Technical analysis trends CIPHER PHARMACEUTICALS INC
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 5,22 $
Spread / Average Target 149%
EPS Revisions
Managers
NameTitle
Robert D. Tessarolo President, Chief Executive Officer & Director
Mark A. Beaudet Chairman
Stephen L. Lemieux Chief Financial Officer & Secretary
John Douglas Mull Independent Director
Christian Godin Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
CIPHER PHARMACEUTICALS INC-43.67%57
JOHNSON & JOHNSON-9.93%337 790
PFIZER3.06%218 540
NOVARTIS-0.24%206 705
ROCHE HOLDING LTD.-5.07%200 737
MERCK AND COMPANY11.11%168 171